reactions. Thus, we set out to develop more powerful
primary amine-based catalytic systems for the enamine
activations.
Asymmetric counteranion-directed catalysis (ACDC)
was recently introduced by List and co-workers as a
powerful strategy in asymmetric catalysis.5 The introduc-
tionof a chiral counteranion tothe catalytic systemenables
the reactions proceeding through cationic intermediates to
be conducted in a highly enantioselective manner; stereo-
chemical control could be effectively induced by the chiral
couteranion. To the best of our knowledge, efficient
catalytic systems engaging chiral counteranions for the
enamine catalysis are yet to be developed. We recently
showed that the combination of 9-amino-9-deoxy-epi-
cinchonine and (þ)-camphorsulfonic acid (CSA) yielded
a new primary amine-based organocatalyst useful for
iminium activation of R,β-unsaturated ketones.6 We rea-
soned that the introduction of a chiral counteranion to the
existing catalyst may result in a more efficient catalytic
system for the enamine activation. Thus, a chiral diamine7
and a chiral acid were selected for the creation of a new ion
pair catalyst (Figure 1).8 Such catalytic systems can be
easily derived via modular assembly of the amino and acid
components. The resulting ammonium moiety in the ion
pair catalyst serves as a Brønsted acid to interact with the
substrate. Moreover, the presence of a chiral counteranion
may further enhance the chiral communications between
the chiral diamine and the substrates. Compared to the
currently existing chiral primary amine catalysts, which
rely on the structural scaffolds of chiral amines for the
asymmetric induction, the proposed ion pair catalyst en-
gages an extra chiral counteranion for stereocontrol. We
hypothesize that judicious selection of the two chiral
components may create a powerful chiral diamineꢀacid
catalyst for an effective enamine catalysis. In this commu-
nication, we document that the combination of a cinchona
alkaloid-derived primary amine and chiral CSA results in a
powerful ion pair catalyst for the enamine activation.
Modified peptides are used extensively in medicinal
chemistry and biological sciences;9 thus, asymmetric
synthesis of optically enriched unnatural amino acids has
Figure 1. Primary amineꢀchiral acid catalytic system for the
enamine catalysis.
been an actively pursued research area in the past few
decades.10 In this context, R,R-disubstituted R-amino acids
are of extreme importance; the presence of a quaternary
carbon center renders these unnatural amino acids with
increased proteolytic stability, and they have been em-
ployed as inhibitors to probe enzymatic mechanisms.
Moreover, their incorporation into peptides provides con-
formational restrictions to the resulting peptides.11 In
particular, the derivatives of R-alkylated phenylglycine
have been shown to be selective group I/group II metabo-
tropic glutamate receptor antagonists,12 in addition to their
potential applications as enzyme inhibitors. Given their
biological significance, an efficient and practical synthesis
of this type of unnatural amino acids is highly desirable.
To demonstrate the power of diamineꢀchiral acid ion
pair catalysts in the enamine catalysis, and to develop an
efficient synthesis of R-alkylated phenylglycine derivatives,
we turnedour attention to the direct amination of branched
aldehydes. In 2002, List and Jørgensen disclosed their
pioneering studies on the proline-catalyzed asymmetric
R-amination of aldehydes.13 Shortly after, Brase showed
€
that proline could catalyze amination of R,R-disubstituted
aldehydes with moderate enantioselectivity.14 Recently, the
same group reported an improved protocol employing
microwave irradiation.15 Proline-derived thiourea was also
utilized by Wang et al. for the same reaction.16 Very
recently, Maruoka disclosed an organocatalytic conjugate
addition of heterosubstituted aldehydes to vinyl sulfones for
(10) (a) Barrett, G. C. In Amino Acids, Peptides and Proteins; The
Royal Society of Chemistry: 1998; Vol. 29. (b) Williams, R. M. Synthesis of
Optically Active R-Amino Acids; Pergamon: Oxford, 1989.
(11) (a) Baldwin, J. E.; Lee, V.; Schofield, C. J. Heterocycles 1992, 34,
903. (b) Shrader, W. D.; Marlowe, C. K. Bioorg. Med. Chem. Lett. 1995,
5, 2207. (c) Badorrey, R.; Cativiela, C.; Diazde-Villegas, M. D.; Galvez,
J. A. Tetrahedron: Asymmetry 1995, 6, 2787. (d) Boyce, R. J.; Mulqueen,
G. C.; Pattenden, G. Tetrahedron 1995, 51, 7321. (e) Gershonov, E.;
Granoth, R.; Tzehoval, E.; Gaoni, Y.; Fridkin, M. J. Med. Chem. 1996,
39, 4833. (f) Williams, R. M.; Hendrix, J. A. Chem. Rev. 1992, 92, 889.
(g) Seebach, D.; Sting, A. R.; Hoffmann, M. Angew. Chem., Int. Ed.
1996, 35, 2708. (h) Wirth, T. Angew. Chem., Int. Ed. 1997, 36, 225.
(12) (a) Bedingfield, J. S.; Kemp, M. C.; Jane, D. E.; Tse, H. W.;
Roberts, P. J.; Watkins, J. C. Br. J. Pharmacol. 1995, 116, 3323.
(b) Sekiyama, N.; Hayashi, Y.; Nakanishi, S.; Jane, D. E.; Tse, H. W.;
Birse, E. F.; Watkins, J. C. Br. J. Pharmacol. 1996, 117, 1493.
(13) (a) List, B. J. Am. Chem. Soc. 2002, 124, 5656. (b) Bogevig, A.;
Juhl, K.; Kumaragurubaran, N.; Zhuang, W.; Jorgensen, K. A. Angew.
Chem., Int. Ed. 2002, 41, 1790.
(5) For the reports from the List group, see: (a) Mayer, S.; List, B.
Angew. Chem., Int. Ed. 2006, 45, 4193. (b) Martin, N. J. A.; List, B.
J. Am. Chem. Soc. 2006, 128, 13368. (c) Mukherjee, S.; List, B. J. Am.
Chem. Soc. 2007, 129, 11336. (d) Wang, X.; List, B. Angew. Chem., Int.
Ed. 2008, 47, 1119. (e) Garcıa-Garcıa, P.; Lay, F.; Garcıa-Garcıa, P.;
Rabalakos, C.; List, B. Angew. Chem., Int. Ed. 2009, 48, 4363. (f) Liao,
S.; List, B. Angew. Chem., Int. Ed. 2010, 49, 628. (g) Zhou, J.; List, B.
J. Am. Chem. Soc. 2007, 129, 7498. (h) Lifchits, O.; Reisinger, C. M.;
List, B. J. Am. Chem. Soc. 2010, 132, 10227. Also see: (i) Hamilton,
G. L.; Kang, E. J.; Mba, M.; Toste, F. D. Science 2007, 317, 496.
(6) Liu, C.; Lu, Y. Org. Lett. 2010, 12, 2278.
(7) For an excellent review on the design of acidꢀbase catalysis, see:
Saito, S.; Yamamoto, H. Acc. Chem. Res. 2004, 37, 570.
(8) For the iminium activations catalyzed by primary amineꢀchiral
acid catalysts, see: (a) Bartoli, G.; Bosco, M.; Carlone, A.; Pesciaioli, F.;
Sambri, L.; Melchiorre, P. Org. Lett. 2007, 9, 1403. (b) Carlone, A.;
Bartoli, G.; Bosco, M.; Pesciaioli, F.; Ricci, P.; Sambri, L.; Melchiorre,
P. Eur. J. Org. Chem. 2007, 5492. (c) Ricci, P.; Carlone, A.; Bartoli, G.;
Bosco, M.; Sambri, L.; Melchiorre, P. Adv. Synth. Catal. 2008, 350, 49.
(d) Xie, J.-W; Huang, X.; Fan, L.-P.; Xu, D.-C.; Li, X.-S.; Su, H.; Wen,
Y.-H. Adv. Synth. Catal. 2009, 351, 3077.
€
(14) Vogt, H.; Vanderheiden, S.; Brase, S. Chem. Commun. 2003, 2448.
€
(15) (a) Baumann, T.; Vogt, H.; Brase, S. Eur. J. Org. Chem. 2007,
€
€
266. (b) Baumann, T.; Bachle, M.; Hartmann, C.; Brase, S. Eur. J. Org.
€
€
Chem. 2008, 2207. (c) Hartmann, C. E.; Baumann, T.; Bachle, M.; Brase,
S. Tetrahedron: Asymmetry 2010, 21, 1341.
(16) Fu, J.-Y.; Xu, X.-Y.; Li, Y.-C.; Huang, Q.-C.; Wang, L.-X. Org.
(9) (a) Crommelin, D. J. A.; Storm, G. Eur. J. Pharm. Sci. 1994, 2, 17.
(b) Kompella, U. B.; Lee, V. H. L. Adv. Drug Delivery Rev. 1992, 8, 115.
Biomol. Chem. 2010, 8, 4524.
Org. Lett., Vol. 13, No. 10, 2011
2639